Guggenheim Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,019
| Closed | -$202K | – | 1682 |
|
|
2025
Q1 | $202K | Sell |
6,019
-158
| -3% | -$5.3K | ﹤0.01% | 1532 |
|
|
2024
Q4 | $242K | Sell |
6,177
-4,452
| -42% | -$175K | ﹤0.01% | 1524 |
|
|
2024
Q3 | $418K | Sell |
10,629
-661
| -6% | -$26K | ﹤0.01% | 1473 |
|
|
2024
Q2 | $440K | Sell |
11,290
-98
| -0.9% | -$3.82K | ﹤0.01% | 1490 |
|
|
2024
Q1 | $490K | Buy |
11,388
+1,859
| +20% | +$80K | ﹤0.01% | 1480 |
|
|
2023
Q4 | $439K | Sell |
9,529
-1,603
| -14% | -$73.8K | ﹤0.01% | 1503 |
|
|
2023
Q3 | $380K | Buy |
11,132
+758
| +7% | +$25.9K | ﹤0.01% | 1543 |
|
|
2023
Q2 | $399K | Sell |
10,374
-8,848
| -46% | -$341K | ﹤0.01% | 1559 |
|
|
2023
Q1 | $688K | Buy |
19,222
+129
| +0.7% | +$4.62K | 0.01% | 1351 |
|
|
2022
Q4 | $753K | Buy |
19,093
+4,155
| +28% | +$164K | 0.01% | 1299 |
|
|
2022
Q3 | $539K | Buy |
14,938
+561
| +4% | +$20.2K | ﹤0.01% | 1443 |
|
|
2022
Q2 | $437K | Buy |
14,377
+184
| +1% | +$5.59K | ﹤0.01% | 1627 |
|
|
2022
Q1 | $434K | Buy |
14,193
+509
| +4% | +$15.6K | ﹤0.01% | 1728 |
|
|
2021
Q4 | $427K | Buy |
13,684
+3,609
| +36% | +$113K | ﹤0.01% | 1760 |
|
|
2021
Q3 | $154K | Buy |
+10,075
| New | +$154K | ﹤0.01% | 2091 |
|